Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsBill Guyer has spoken on 4 earnings calls across 1 company, most recently for Corcept Therapeutics Inc on November 3, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
“So thanks for the question, Kripa, and thank you for joining us today. So when you look at MASH and miracoralant, we learned some great things from the Monarch study that you heard from Joe.”
“So, one, I want to respect what we're going to present at SGO and not give you too much details, but yet still try to answer your question, as well as respect our publication that we hope to have come out as soon as possible as well.”
“Now, in order to understand the scope of our opportunity in oncology, I think it helps to recall that our program follows groundbreaking insights made by investigators at the University of Chicago, who hypothesize that cortisol activity at the glucocorticoid receptor promotes solid tumor growth in three ways.”
“So, for the BELLA trial, enrollment has gone better than expected. I mean, our Phase 2 and a Phase 3 study is using Reliquolin Plus NAP, Pactitaxel enrolled also very quickly.”
Source not stated
Biotechnology · Healthcare
